When the Feds Come Marching In: A Deep Dive on The Bayh-Dole Act

Joe Allen, Executive Director of The Bayh-Dole Coalition, was at the forefront of the Bayh-Dole Act back in December 1980, which allowed researchers to own inventions resulting from federally funded research. However, 43 years later, the March-In Rights framework proposed by the Biden administration threatens to weaken America’s innovation. In this episode, Joe delves into the potential implications of this framework on drug pricing, the pipeline, and overall innovation.Join us as we discuss:The significance of the Bayh-Dole Act and intellectual property in transforming how America drives innovation.Why public-private partnerships and collaboration in the medical field are key for funding research projects.The implications of enacting March-In Rights on the drug development pipeline